[go: up one dir, main page]

ES2107375B1 - Formulaciones farmaceuticas liquidas de ebastina por via oral. - Google Patents

Formulaciones farmaceuticas liquidas de ebastina por via oral.

Info

Publication number
ES2107375B1
ES2107375B1 ES9501556A ES9501556A ES2107375B1 ES 2107375 B1 ES2107375 B1 ES 2107375B1 ES 9501556 A ES9501556 A ES 9501556A ES 9501556 A ES9501556 A ES 9501556A ES 2107375 B1 ES2107375 B1 ES 2107375B1
Authority
ES
Spain
Prior art keywords
liquid pharmaceutical
pharmaceutical formulations
ebastin
oral way
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9501556A
Other languages
English (en)
Other versions
ES2107375A1 (es
Inventor
Jose Luis Fabregas
Mauri Jacinto Moraques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma SA filed Critical Almirall Prodesfarma SA
Priority to ES9501556A priority Critical patent/ES2107375B1/es
Publication of ES2107375A1 publication Critical patent/ES2107375A1/es
Application granted granted Critical
Publication of ES2107375B1 publication Critical patent/ES2107375B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORMULACIONES FARMACEUTICAS LIQUIDAS DE EBASTINA POR VIA ORAL. FORMULACIONES FARMACEUTICAS LIQUIDAS DE 4 -DIFENILMETOXI -1- [3- (4-TERBUTILBENZOIL) PROPIL] PIPERIDINA, CUYA DENOMINACION COMAN ES EBASTINA, QUE CONTIENEN ACIDOS CARBOXILICOS HIDROXILADOS, TENSIOACTIVOS NO IONICOS Y POLIOLES DE CADENA MEDIA EN UNA PROPORCION COMPRENDIDA ENTRE 1:1:3:25 Y 3:10:25:500 RESPECTIVAMENTE, JUNTO CON EXCIPIENTES O DILUYENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS FORMULACIONES SE UTILIZAN PARA EL TRATAMIENTO DE PROCESOS ALERGICOS COMO RINITIS, URTICARIA, DERMATITIS O CONJUNTIVITIS.
ES9501556A 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral. Expired - Fee Related ES2107375B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9501556A ES2107375B1 (es) 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9501556A ES2107375B1 (es) 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral.

Publications (2)

Publication Number Publication Date
ES2107375A1 ES2107375A1 (es) 1997-11-16
ES2107375B1 true ES2107375B1 (es) 1998-07-01

Family

ID=8291245

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9501556A Expired - Fee Related ES2107375B1 (es) 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral.

Country Status (1)

Country Link
ES (1) ES2107375B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013081562A1 (en) 2011-10-13 2013-06-06 Mahmut Bilgic Oral formulations comprising ebastine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568473B1 (fr) * 1984-08-03 1987-05-15 Vaillant Defresne Laboratoire Nouvelle composition a base de formiate de quinine
FR2624736B1 (fr) * 1987-12-16 1991-03-22 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Also Published As

Publication number Publication date
ES2107375A1 (es) 1997-11-16

Similar Documents

Publication Publication Date Title
NO971206D0 (no) Forlenget-frigjöringsformulering
CR9842A (es) Composiciones de celecoxib
NO951613L (no) Ikke-peptidyl tachykinin reseptorantagonister
DE59508891D1 (de) Hautpflegemittel
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
PT994710E (pt) Composicoes farmaceuticas administraveis por via oral incluindo uma benzidrilpiperazina e uma ciclodextrina
MA26901A1 (fr) Nouvelle composition pharmaceutique
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
ES2159591T3 (es) Composicion de liberacion controlada.
AR018197A1 (es) Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
NO961687D0 (no) Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner
GT199800101A (es) Composicion farmaceutica solida que contiene un derivado de benzofurano.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
GB0222514D0 (en) Organic compounds
SV2002000235A (es) Composiciones farmaceuticas que comprenden valdecoxib
GT199700037A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
ATE87468T1 (de) Antacidatabletten.
ES2107375B1 (es) Formulaciones farmaceuticas liquidas de ebastina por via oral.
SE0001916D0 (sv) Novel formulation

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971116

Kind code of ref document: A1

Effective date: 19971116

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20180806